Detalles de la búsqueda
1.
Bevacizumab Combined with S-1 and Raltitrexed for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies: A Phase II Study.
Oncologist
; 26(8): e1320-e1326, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33830591
2.
Enhancement of the antitumor effect of HER2-directed CAR-T cells through blocking epithelial-mesenchymal transition in tumor cells.
FASEB J
; 34(8): 11185-11199, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645243
3.
IL-18R-dependent and independent pathways account for IL-18-enhanced antitumor ability of CAR-T cells.
FASEB J
; 34(1): 1768-1782, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31914650
4.
S-1 plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial.
Oncologist
; 24(5): 591-e165, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30651398
5.
Improved therapeutic potential of MSCs by genetic modification.
Gene Ther
; 25(8): 538-547, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30254305
6.
A case of penile squamous cell carcinoma treated with a combination of antiepidermal growth factor receptor antibody and chemotherapy.
Anticancer Drugs
; 25(1): 123-5, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24263192
7.
Dynamic ctDNA-based analysis of drug-resistant gene alterations at RAS/BRAF wild-type metastatic colorectal cancer patients after cetuximab plus chemotherapy as the first-line treatment.
Int Immunopharmacol
; 131: 111887, 2024 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38503018
8.
Clinical characteristics of patients with solitary pulmonary mass after radical treatment for primary cancers: pulmonary metastasis or second primary lung cancer?
Cancer Invest
; 31(6): 397-403, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23758185
9.
[Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in penile cancer].
Sichuan Da Xue Xue Bao Yi Xue Ban
; 44(5): 756-9, 2013 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-24325106
10.
Case report: Remarkable response to sintilimab, lenvatinib, and nab-paclitaxel in postoperative metastatic chemotherapy-resistant combined hepatocellular-cholangiocarcinoma.
Front Pharmacol
; 14: 1190967, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37900166
11.
Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study.
Eur J Surg Oncol
; 48(7): 1559-1566, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35115213
12.
Antiemetic activity of megestrol acetate in patients receiving chemotherapy.
Support Care Cancer
; 19(5): 667-73, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20419494
13.
First-line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component.
Cancer Med
; 10(10): 3388-3402, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33939281
14.
ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma.
Medicine (Baltimore)
; 99(14): e19413, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243360
15.
Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer.
Front Oncol
; 10: 570268, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33324548
16.
Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications.
BMC Cancer
; 9: 432, 2009 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20003271
17.
[Relationship between clinicopathologic characteristics and expression of VEGF-C and VEGF-D in esophageal squamous cancer].
Sichuan Da Xue Xue Bao Yi Xue Ban
; 40(2): 240-4, 2009 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-19462898
18.
Preclinical Evaluation of Chimeric Antigen Receptor-Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer.
Hum Gene Ther
; 30(4): 402-412, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30693795
19.
Correction: Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis.
Cell Death Dis
; 10(10): 722, 2019 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31558703
20.
Cost-effectiveness analysis of chemotherapy for advanced gastric cancer in China.
World J Gastroenterol
; 14(17): 2715-22, 2008 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-18461656